Kevin A. Lobo has been CEO of Stryker since October 1, 2012, and also assumed the role of Chair of the Board on July 22, 2014. He joined Stryker in 2011 and had previously been Group President of Orthopaedics.
Mr. Lobo serves on the board of directors for Parker Hannifin Corporation (NYSE:PH) and the U.S.-India Business Council. He is also a member of the Business Roundtable and Business Council. Mr. Lobo recently served as chairman of the Advanced Medical Technology Association (AdvaMed) Board of Directors.
Mr. Lobo has a broad business career across multiple industries. After holding finance positions with KPMG, Unilever and Kraft Canada, he spent eight years with Rhone-Poulenc, including roles based in Europe as Corporate Controller of a chemical spin-out and General Manager of Specialty Phosphates EMEA. He then spent eight years at Johnson & Johnson, including President of Ethicon Endo Surgery.